Gene · 4241
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of force fields to study the zinc-finger containing protein NPL4, a target for disulfiram in cancer therapy. | Biochim Biophys Acta Proteins Proteom | 2023 | 37230374 | PubTator, text mining | PubMed |
| Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer. | Cancer Metab | 2023 | 37226257 | PubTator, text mining | PubMed |
| Experimental Support for Human Papillomavirus Genome Amplification Early after Infectious Delivery. | J Virol | 2023 | 37223953 | PubTator, text mining | PubMed |
| Depiction of neuroendocrine features associated with immunotherapy response using a novel one-class predictor in lung adenocarcinoma. | Discov Oncol | 2023 | 37199872 | PubTator, text mining | PubMed |
| Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer. | Cancers (Basel) | 2023 | 37190188 | PubTator, text mining | PubMed |
| Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? | Biomolecules | 2023 | 37189352 | PubTator, text mining | PubMed |
| Construction of an interferon regulatory factors-related risk model for predicting prognosis, immune microenvironment and immunotherapy in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37182129 | PubTator, text mining | PubMed |
| Chromosomal Microarray in Patients with Non-Syndromic Autism Spectrum Disorders in the Clinical Routine of a Tertiary Hospital. | Genes (Basel) | 2023 | 37107578 | PubTator, text mining | PubMed |
| RAD51 bypasses the CMG helicase to promote replication fork reversal. | Science | 2023 | 37104614 | PubTator, text mining | PubMed |
| UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer. | Oncogene | 2023 | 37037900 | PubTator, text mining | PubMed |
| Bcs1, a novel target for fungicide. | Front Chem | 2023 | 36993815 | PubTator, text mining | PubMed |
| Digital spatial profiling of human parathyroid tumors reveals cellular and molecular alterations linked to vitamin D deficiency. | PNAS Nexus | 2023 | 36992820 | PubTator, text mining | PubMed |
| The Impact of Processing and Extraction Methods on the Allergenicity of Targeted Protein Quantification as Well as Bioactive Peptides Derived from Egg. | Molecules | 2023 | 36985630 | PubTator, text mining | PubMed |
| DNA Repair and Therapeutic Strategies in Cancer Stem Cells. | Cancers (Basel) | 2023 | 36980782 | PubTator, text mining | PubMed |
| Screening of EWI-2-Derived Peptides for Targeting Tetraspanin CD81 and Their Effect on Cancer Cell Migration. | Biomolecules | 2023 | 36979448 | PubTator, text mining | PubMed |
| Extrachromosomal Amplification of Human Papillomavirus Episomes Is a Mechanism of Cervical Carcinogenesis. | Cancer Res | 2023 | 36971511 | PubTator, text mining | PubMed |
| Exosomal MFI2-AS1 sponge miR-107 promotes non-small cell lung cancer progression through NFAT5. | Cancer Cell Int | 2023 | 36934264 | PubTator, text mining | PubMed |
| LncRNA HAGLR silencing inhibits IL-1β-induced chondrocytes inflammatory injury via miR-130a-3p/JAK1 axis. | J Orthop Surg Res | 2023 | 36918905 | PubTator, text mining | PubMed |
| Targeting endoplasmic reticulum associated degradation pathway combined with radiotherapy enhances the immunogenicity of esophageal cancer cells. | Cancer Biol Ther | 2023 | 36907982 | PubTator, text mining | PubMed |
| An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma. | Front Genet | 2023 | 36845390 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4241/papers?page=7